China near-infrared imaging market is anticipated to grow at a CAGR around 10.3% during the forecast period. The driving factors that augmented the market include the prevalence of chronic diseases such as cardiovascular and cancer diseases. The cancer is the fifth leading cause of mortality in China related to lung and bronchus, stomach, colorectum, esophagus, liver. The government of China is now investing heavily to transform its life science sector and established national laboratories for stem cell research, infectious diseases and drug development medical devices and biologics. Aging population, smoking, sedentary work style, physical inactivity, excessive alcohol consumption, hypertension, poor diet, obesity, and overweight are the risk factors in the rise of heart diseases.
To Request a Sample of our Report on China Near Infrared Imaging Market: https://www.omrglobal.com/request-sample/china-near-infrared-imaging-market
China’s near-infrared imaging market is segmented on the basis of disease and technology. Based on disease, the market is segmented into cancer surgeries, gastrointestinal surgeries, cardiovascular surgeries, and plastic surgeries. Based on technology, the market is segmented into fluorescence imaging and bioluminescence imaging.
(Get 15% Discount on Buying this Report)
A full Report of China Near Infrared Imaging Market is Available at: https://www.omrglobal.com/industry-reports/china-near-infrared-imaging-market
China Near Infrared Imaging Market Segmentation
By Disease
- Cancer Surgeries
- Gastrointestinal Surgeries
- Cardiovascular Surgeries
- Plastic Surgeries
By Technology
- Fluorescence Imaging
- Fluorescence Reflectance Imaging (FRI)
- Tomographic Fluorescence Imaging
- Bioluminescence Imaging
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
